Induction of Fas-mediated apoptosis in a human renal epithelial cell line by interferon-γ: Involvement of Fas-mediated apoptosis in acute renal rejection

Modern Pathology

Volumn 11, Issue 11, 1998, Pages 1107-1114

  Akasaka, Yoshikiyo ^a,c   Ishikawa, Yukio ^a   Kato, Shigeo ^a   Ishii, Toshiharu ^a   Masuda, Takao ^a   Fujita, Kazuko ^b   Yamada, Takeshi ^b   Kawamura, Sadao ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Allograft rejection; Apoptosis; Fas; Fas ligand; Kidney

Indexed keywords

BIOTIN; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; TRANSFERASE;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BIOPSY; CHILD; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY EPITHELIUM; KIDNEY TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACUTE DISEASE; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOPSY; CELL LINE; EPITHELIAL CELLS; FAS LIGAND PROTEIN; GENE EXPRESSION; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERFERON TYPE II; KIDNEY; KIDNEY TRANSPLANTATION; MEMBRANE GLYCOPROTEINS; RNA, MESSENGER;

EID: 0031727591     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, et al. Expression of the Fas ligand in cells of T-cell lineage. J Immunol 1995;154:3806-13.
2. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994;76:969-76.
3. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-9.
4. Higaki K, Yano H, Kojiro M. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Am J Pathol 1996;149:429-37.
5. Nozawa K, Kayagaki N, Tokano Y, Yagita H, Okumura K, Hasimoto H. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases. Arthritis Rheum 1997;40:1126-9.
6. Kelly CJ, Roth DA, Meyers CM. Immune recognition and response to the renal interstitium. Kidney Int 1991;31:518-30.
7. Weiss RA, Madaio MP, Tomaszewski JE, Kelly CJ. T cells reactive to an inducible heat shock protein induce disease in a model of toxin-induced interstitial nephritis. J Exp Med 1994;180:2239-50.
8. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin PB, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993;44:411-22.
9. Krajeweska M, Krajeweski S, Epstein JI, Shabaik A, Sauvageot J, Song K, et al. Immunohistochemical analysis of bcl-2, bax, bcl-x, and mcl-1 expression in prostate cancers. Am J Pathol 1996;148:1567-76.
10. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
11. Sharma VK, Bologa RM, Li B, Xu GP, Lagman M, Hiscock W, et al. Molecular executors of cell death: differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation 1996;62:1860-6.
12. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F. The Fas-counterattack: Fas-mediated T-cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996;184:1075-82.
13. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human β-actin cDNA. Nucleic Acids Res 1984;12:1687-96.
14. Ito N, Yonehara S, Ishi A, Yonehara M, Mizushima S, Sameshima M, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
15. Ogasawara J, Wanatabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y. et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-9.
16. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306.
17. Andersen CB, Ladefoged SD, Larsen S. Acute kidney graft rejection: a morphological and immunological study on zero-hour and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules. APMIS 1994;102: 23-37.
18. Strehlau J, Pavlakis M, Lipman M, Shapiro M, Vasconcellos L, Harmon W, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci U S A 1997;94:695-700.
19. Matsuno T, Sasaki N, Ishido K, Nakagawa K, Ishikawa T, Oishi A, et al. Apoptosis in human kidney allografts. Transplantat Proc 1996;28:1226-7.
20. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, et al. Constitutive and induced expression of Apo-1, a new member of the nerve growth factor / tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993;69:415-29.
21. Ortiz-Arduan A, Danoff TM, Kalluri R, González-Cuadrado S, Karp SL, Elkon K, et al. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol 1996;271:1193-201.
22. Xerri L, Devilard E, Hassoun J, Mawas C, Birg F. Fas ligand is not only expressed in immune-privileged human organ but is also coexpressed with Fas in various epithelial tissues. J Clin Pathol 1997;50:87-91.
23. Hata H, Matsuzaki H, Takeya M, Yoshida M, Sonoki T, Nagasaki A, et al. Expression of Fas/Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders. Blood 1995;86:1939-45.
24. Maciejewski J, Selleri C, Anderson S, Young NS. Fas antigen expression on CD34+ human marrow cells is induced by Interferon-γ and tumor necrosis factor A potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995;85:3183-90.
25. Takahashi H, Kobayashi H, Hashimoto Y, Matsuo S, Iizuka H. Interferon-γ-dependent stimulation of Fas antigen in SV40-transformed human keratinocytes: modulation of the apoptotic process by protein kinase C. J Invest Dermatol 1995;105:810-5.
26. Yano H, Fukuda K, Haramaki M, Momosaki S, Ogasawara S, Higaki K, et al. Expression of Fas and Fas-mediated apoptosis in human hepatocellular carcinoma cell lines. J Hepatology 1996;25:454-64.
27. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-7.
28. Swenson KM, Ke B, Wang T, Markowitz JS, Maggard MA, Spear GS, et al. Fas ligand gene transfer to renal allografts in rats. Transplantation 1998;65:155-60.
29. Larsen CP, Alexander DZ, Hendrix R, Ritchie SC, Pearson TC. Fas-mediated cytotoxicity. Transplantation 1995;60:221-4.
30. McCarthy SA, Cacchione RN, Mainwaring MS, Cairns JS. The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. Transplantation 1992;54:543-7.
31. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6.
32. Ito H, Kasagi N, Shomori K, Osaki M, Adachi H. Apoptosis in the human allografted kidney. Transplantation 1995;60:794-8.
33. Prashar Y, Khanna A, Sehajpal P, Sharma V, Suthanthiran M. Stimulation of transforming growth factor-β 1 transcription by cyclosporine. FEBS Lett 1995;358:109-12.
34. Bursch W, Oberhammer F, Jirtle RL, Askari M, Sedivy R, Grasl-Kraupp B, et al. Transforming growth factor-β 1 as a signal of cell death by apoptosis. Br J Cancer 1993;67: 531-6.